West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript July 25, 2024
West Pharmaceutical Services, Inc. misses on earnings expectations. Reported EPS is $1.51 EPS, expectations were $1.77.
John Sweeney: Good morning, and welcome to West’s Second Quarter 2024 Conference Call. By way of introduction, this is John Sweeney, the new Head of Investor Relations at West. I’m delighted to be here and I look forward to working with all of you. We issued our financial results...
